nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—ABCB1—peripheral nervous system neoplasm	0.229	1	CbGaD
Lovastatin—UGT2B7—Epirubicin—peripheral nervous system neoplasm	0.0584	0.107	CbGbCtD
Lovastatin—UGT1A1—Etoposide—peripheral nervous system neoplasm	0.0393	0.0724	CbGbCtD
Lovastatin—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0379	0.0699	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0379	0.0699	CbGbCtD
Lovastatin—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0285	0.0524	CbGbCtD
Lovastatin—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0274	0.0504	CbGbCtD
Lovastatin—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0261	0.0481	CbGbCtD
Lovastatin—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0243	0.0448	CbGbCtD
Lovastatin—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0239	0.044	CbGbCtD
Lovastatin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0199	0.0367	CbGbCtD
Lovastatin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0199	0.0367	CbGbCtD
Lovastatin—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0191	0.0352	CbGbCtD
Lovastatin—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0174	0.0321	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0174	0.0321	CbGbCtD
Lovastatin—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0163	0.03	CbGbCtD
Lovastatin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0138	0.0254	CbGbCtD
Lovastatin—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0131	0.0241	CbGbCtD
Lovastatin—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.012	0.0221	CbGbCtD
Lovastatin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0119	0.022	CbGbCtD
Lovastatin—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0115	0.0212	CbGbCtD
Lovastatin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0111	0.0204	CbGbCtD
Lovastatin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00851	0.0157	CbGbCtD
Lovastatin—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00817	0.0151	CbGbCtD
Lovastatin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00793	0.0146	CbGbCtD
Lovastatin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00779	0.0144	CbGbCtD
Lovastatin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00532	0.00979	CbGbCtD
Lovastatin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0051	0.00939	CbGbCtD
Lovastatin—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00501	0.00923	CbGbCtD
Lovastatin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00467	0.0086	CbGbCtD
Lovastatin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00319	0.00587	CbGbCtD
Lovastatin—HDAC2—Teniposide—Etoposide—peripheral nervous system neoplasm	0.00195	1	CbGdCrCtD
Lovastatin—Simvastatin—ABCB1—peripheral nervous system neoplasm	0.000978	0.505	CrCbGaD
Lovastatin—Pravastatin—ABCB1—peripheral nervous system neoplasm	0.000957	0.495	CrCbGaD
Lovastatin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000174	0.000966	CcSEcCtD
Lovastatin—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.00096	CcSEcCtD
Lovastatin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000173	0.000958	CcSEcCtD
Lovastatin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000173	0.000958	CcSEcCtD
Lovastatin—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.000953	CcSEcCtD
Lovastatin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000171	0.000946	CcSEcCtD
Lovastatin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000171	0.000946	CcSEcCtD
Lovastatin—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000945	CcSEcCtD
Lovastatin—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00017	0.000943	CcSEcCtD
Lovastatin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00017	0.000943	CcSEcCtD
Lovastatin—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00017	0.000942	CcSEcCtD
Lovastatin—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000169	0.00094	CcSEcCtD
Lovastatin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000169	0.000936	CcSEcCtD
Lovastatin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000168	0.000934	CcSEcCtD
Lovastatin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000168	0.000933	CcSEcCtD
Lovastatin—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000168	0.000932	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000168	0.000932	CcSEcCtD
Lovastatin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000167	0.000926	CcSEcCtD
Lovastatin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000167	0.000926	CcSEcCtD
Lovastatin—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000167	0.000925	CcSEcCtD
Lovastatin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000166	0.000922	CcSEcCtD
Lovastatin—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000166	0.000918	CcSEcCtD
Lovastatin—Malaise—Etoposide—peripheral nervous system neoplasm	0.000165	0.000915	CcSEcCtD
Lovastatin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000165	0.000915	CcSEcCtD
Lovastatin—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000164	0.000912	CcSEcCtD
Lovastatin—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000164	0.000908	CcSEcCtD
Lovastatin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000164	0.000907	CcSEcCtD
Lovastatin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000164	0.000907	CcSEcCtD
Lovastatin—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000907	CcSEcCtD
Lovastatin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000163	0.000905	CcSEcCtD
Lovastatin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000163	0.000905	CcSEcCtD
Lovastatin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000163	0.000904	CcSEcCtD
Lovastatin—Infection—Cisplatin—peripheral nervous system neoplasm	0.000162	0.000898	CcSEcCtD
Lovastatin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000162	0.000897	CcSEcCtD
Lovastatin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000161	0.00089	CcSEcCtD
Lovastatin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000161	0.00089	CcSEcCtD
Lovastatin—Rash—Topotecan—peripheral nervous system neoplasm	0.00016	0.00089	CcSEcCtD
Lovastatin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00016	0.000889	CcSEcCtD
Lovastatin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00016	0.000889	CcSEcCtD
Lovastatin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00016	0.000885	CcSEcCtD
Lovastatin—Headache—Topotecan—peripheral nervous system neoplasm	0.000159	0.000884	CcSEcCtD
Lovastatin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000159	0.000883	CcSEcCtD
Lovastatin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000159	0.000883	CcSEcCtD
Lovastatin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000159	0.000882	CcSEcCtD
Lovastatin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000159	0.000882	CcSEcCtD
Lovastatin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000159	0.000882	CcSEcCtD
Lovastatin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000158	0.000879	CcSEcCtD
Lovastatin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000158	0.000877	CcSEcCtD
Lovastatin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000158	0.000877	CcSEcCtD
Lovastatin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000158	0.000874	CcSEcCtD
Lovastatin—Pain—Vincristine—peripheral nervous system neoplasm	0.000158	0.000874	CcSEcCtD
Lovastatin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000158	0.000874	CcSEcCtD
Lovastatin—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000874	CcSEcCtD
Lovastatin—Rash—Melphalan—peripheral nervous system neoplasm	0.000157	0.000871	CcSEcCtD
Lovastatin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000157	0.000871	CcSEcCtD
Lovastatin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000156	0.000868	CcSEcCtD
Lovastatin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000156	0.000864	CcSEcCtD
Lovastatin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000155	0.000862	CcSEcCtD
Lovastatin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000154	0.000854	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000851	CcSEcCtD
Lovastatin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000152	0.000843	CcSEcCtD
Lovastatin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.000843	CcSEcCtD
Lovastatin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.000839	CcSEcCtD
Lovastatin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.000839	CcSEcCtD
Lovastatin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000151	0.000838	CcSEcCtD
Lovastatin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000151	0.000836	CcSEcCtD
Lovastatin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000151	0.000835	CcSEcCtD
Lovastatin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00015	0.000832	CcSEcCtD
Lovastatin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00015	0.000832	CcSEcCtD
Lovastatin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000149	0.000828	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000824	CcSEcCtD
Lovastatin—Infection—Etoposide—peripheral nervous system neoplasm	0.000148	0.000823	CcSEcCtD
Lovastatin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000148	0.000821	CcSEcCtD
Lovastatin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000148	0.000821	CcSEcCtD
Lovastatin—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000816	CcSEcCtD
Lovastatin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000146	0.000812	CcSEcCtD
Lovastatin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000146	0.000811	CcSEcCtD
Lovastatin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000808	CcSEcCtD
Lovastatin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000146	0.000808	CcSEcCtD
Lovastatin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000146	0.000808	CcSEcCtD
Lovastatin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000145	0.000806	CcSEcCtD
Lovastatin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000144	0.0008	CcSEcCtD
Lovastatin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000142	0.00079	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000787	CcSEcCtD
Lovastatin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000142	0.000786	CcSEcCtD
Lovastatin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000141	0.000783	CcSEcCtD
Lovastatin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.000782	CcSEcCtD
Lovastatin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000139	0.000773	CcSEcCtD
Lovastatin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000137	0.000761	CcSEcCtD
Lovastatin—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000755	CcSEcCtD
Lovastatin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000136	0.000753	CcSEcCtD
Lovastatin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000135	0.000751	CcSEcCtD
Lovastatin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000748	CcSEcCtD
Lovastatin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000745	CcSEcCtD
Lovastatin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000134	0.000745	CcSEcCtD
Lovastatin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000134	0.000744	CcSEcCtD
Lovastatin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000741	CcSEcCtD
Lovastatin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000133	0.000738	CcSEcCtD
Lovastatin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000132	0.000734	CcSEcCtD
Lovastatin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000131	0.000728	CcSEcCtD
Lovastatin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000131	0.000726	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000722	CcSEcCtD
Lovastatin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00013	0.000722	CcSEcCtD
Lovastatin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00013	0.00072	CcSEcCtD
Lovastatin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000129	0.000715	CcSEcCtD
Lovastatin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000129	0.000714	CcSEcCtD
Lovastatin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000714	CcSEcCtD
Lovastatin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000128	0.000708	CcSEcCtD
Lovastatin—Pain—Etoposide—peripheral nervous system neoplasm	0.000128	0.000708	CcSEcCtD
Lovastatin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000708	CcSEcCtD
Lovastatin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000127	0.000702	CcSEcCtD
Lovastatin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000126	0.0007	CcSEcCtD
Lovastatin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.00069	CcSEcCtD
Lovastatin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000683	CcSEcCtD
Lovastatin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000123	0.000683	CcSEcCtD
Lovastatin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000123	0.00068	CcSEcCtD
Lovastatin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000122	0.000677	CcSEcCtD
Lovastatin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000122	0.000676	CcSEcCtD
Lovastatin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000122	0.000675	CcSEcCtD
Lovastatin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000121	0.000669	CcSEcCtD
Lovastatin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000121	0.000668	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000668	CcSEcCtD
Lovastatin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000666	CcSEcCtD
Lovastatin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00012	0.000665	CcSEcCtD
Lovastatin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00066	CcSEcCtD
Lovastatin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000119	0.000658	CcSEcCtD
Lovastatin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000118	0.000655	CcSEcCtD
Lovastatin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000118	0.000655	CcSEcCtD
Lovastatin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000655	CcSEcCtD
Lovastatin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000653	CcSEcCtD
Lovastatin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000117	0.00065	CcSEcCtD
Lovastatin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000117	0.000649	CcSEcCtD
Lovastatin—Rash—Vincristine—peripheral nervous system neoplasm	0.000116	0.000645	CcSEcCtD
Lovastatin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000116	0.000644	CcSEcCtD
Lovastatin—Headache—Vincristine—peripheral nervous system neoplasm	0.000116	0.000641	CcSEcCtD
Lovastatin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000632	CcSEcCtD
Lovastatin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.00063	CcSEcCtD
Lovastatin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000112	0.000619	CcSEcCtD
Lovastatin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000618	CcSEcCtD
Lovastatin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00011	0.00061	CcSEcCtD
Lovastatin—Nausea—Vincristine—peripheral nervous system neoplasm	0.00011	0.000607	CcSEcCtD
Lovastatin—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000606	CcSEcCtD
Lovastatin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000605	CcSEcCtD
Lovastatin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000107	0.000594	CcSEcCtD
Lovastatin—Chills—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000586	CcSEcCtD
Lovastatin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000106	0.000586	CcSEcCtD
Lovastatin—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000577	CcSEcCtD
Lovastatin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000104	0.000575	CcSEcCtD
Lovastatin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000572	CcSEcCtD
Lovastatin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000103	0.00057	CcSEcCtD
Lovastatin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000103	0.00057	CcSEcCtD
Lovastatin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000102	0.000567	CcSEcCtD
Lovastatin—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000561	CcSEcCtD
Lovastatin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000561	CcSEcCtD
Lovastatin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000557	CcSEcCtD
Lovastatin—Back pain—Epirubicin—peripheral nervous system neoplasm	9.92e-05	0.00055	CcSEcCtD
Lovastatin—Dizziness—Etoposide—peripheral nervous system neoplasm	9.88e-05	0.000548	CcSEcCtD
Lovastatin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.000547	CcSEcCtD
Lovastatin—Chills—Doxorubicin—peripheral nervous system neoplasm	9.78e-05	0.000543	CcSEcCtD
Lovastatin—Nausea—Cisplatin—peripheral nervous system neoplasm	9.68e-05	0.000537	CcSEcCtD
Lovastatin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	9.67e-05	0.000536	CcSEcCtD
Lovastatin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	9.63e-05	0.000534	CcSEcCtD
Lovastatin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000528	CcSEcCtD
Lovastatin—Vomiting—Etoposide—peripheral nervous system neoplasm	9.5e-05	0.000527	CcSEcCtD
Lovastatin—Rash—Etoposide—peripheral nervous system neoplasm	9.42e-05	0.000522	CcSEcCtD
Lovastatin—Dermatitis—Etoposide—peripheral nervous system neoplasm	9.41e-05	0.000522	CcSEcCtD
Lovastatin—Headache—Etoposide—peripheral nervous system neoplasm	9.36e-05	0.000519	CcSEcCtD
Lovastatin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	9.35e-05	0.000519	CcSEcCtD
Lovastatin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	9.29e-05	0.000515	CcSEcCtD
Lovastatin—Malaise—Epirubicin—peripheral nervous system neoplasm	9.25e-05	0.000513	CcSEcCtD
Lovastatin—Vertigo—Epirubicin—peripheral nervous system neoplasm	9.22e-05	0.000511	CcSEcCtD
Lovastatin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	9.18e-05	0.000509	CcSEcCtD
Lovastatin—Back pain—Doxorubicin—peripheral nervous system neoplasm	9.18e-05	0.000509	CcSEcCtD
Lovastatin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.000506	CcSEcCtD
Lovastatin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	8.95e-05	0.000496	CcSEcCtD
Lovastatin—Nausea—Etoposide—peripheral nervous system neoplasm	8.87e-05	0.000492	CcSEcCtD
Lovastatin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	8.81e-05	0.000488	CcSEcCtD
Lovastatin—Myalgia—Epirubicin—peripheral nervous system neoplasm	8.73e-05	0.000484	CcSEcCtD
Lovastatin—Chest pain—Epirubicin—peripheral nervous system neoplasm	8.73e-05	0.000484	CcSEcCtD
Lovastatin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	8.73e-05	0.000484	CcSEcCtD
Lovastatin—Anxiety—Epirubicin—peripheral nervous system neoplasm	8.7e-05	0.000483	CcSEcCtD
Lovastatin—Discomfort—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000479	CcSEcCtD
Lovastatin—Malaise—Doxorubicin—peripheral nervous system neoplasm	8.56e-05	0.000475	CcSEcCtD
Lovastatin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	8.54e-05	0.000474	CcSEcCtD
Lovastatin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000473	CcSEcCtD
Lovastatin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	8.5e-05	0.000471	CcSEcCtD
Lovastatin—Confusional state—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000468	CcSEcCtD
Lovastatin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	8.37e-05	0.000464	CcSEcCtD
Lovastatin—Infection—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000461	CcSEcCtD
Lovastatin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000455	CcSEcCtD
Lovastatin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	8.08e-05	0.000448	CcSEcCtD
Lovastatin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	8.08e-05	0.000448	CcSEcCtD
Lovastatin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	8.08e-05	0.000448	CcSEcCtD
Lovastatin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	8.05e-05	0.000447	CcSEcCtD
Lovastatin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000443	CcSEcCtD
Lovastatin—Anorexia—Epirubicin—peripheral nervous system neoplasm	7.98e-05	0.000443	CcSEcCtD
Lovastatin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000438	CcSEcCtD
Lovastatin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000433	CcSEcCtD
Lovastatin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	7.75e-05	0.00043	CcSEcCtD
Lovastatin—Infection—Doxorubicin—peripheral nervous system neoplasm	7.7e-05	0.000427	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	7.63e-05	0.000423	CcSEcCtD
Lovastatin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	7.58e-05	0.000421	CcSEcCtD
Lovastatin—Insomnia—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.00042	CcSEcCtD
Lovastatin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	7.52e-05	0.000417	CcSEcCtD
Lovastatin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000414	CcSEcCtD
Lovastatin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	7.38e-05	0.000409	CcSEcCtD
Lovastatin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	7.37e-05	0.000409	CcSEcCtD
Lovastatin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	7.28e-05	0.000404	CcSEcCtD
Lovastatin—Fatigue—Epirubicin—peripheral nervous system neoplasm	7.22e-05	0.0004	CcSEcCtD
Lovastatin—Pain—Epirubicin—peripheral nervous system neoplasm	7.16e-05	0.000397	CcSEcCtD
Lovastatin—Constipation—Epirubicin—peripheral nervous system neoplasm	7.16e-05	0.000397	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.000391	CcSEcCtD
Lovastatin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.000389	CcSEcCtD
Lovastatin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	6.96e-05	0.000386	CcSEcCtD
Lovastatin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	6.91e-05	0.000383	CcSEcCtD
Lovastatin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	6.9e-05	0.000383	CcSEcCtD
Lovastatin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	6.85e-05	0.00038	CcSEcCtD
Lovastatin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	6.82e-05	0.000378	CcSEcCtD
Lovastatin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	6.73e-05	0.000373	CcSEcCtD
Lovastatin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.00037	CcSEcCtD
Lovastatin—Urticaria—Epirubicin—peripheral nervous system neoplasm	6.65e-05	0.000369	CcSEcCtD
Lovastatin—Constipation—Doxorubicin—peripheral nervous system neoplasm	6.62e-05	0.000367	CcSEcCtD
Lovastatin—Pain—Doxorubicin—peripheral nervous system neoplasm	6.62e-05	0.000367	CcSEcCtD
Lovastatin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	6.62e-05	0.000367	CcSEcCtD
Lovastatin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	6.62e-05	0.000367	CcSEcCtD
Lovastatin—HMGCR—Metabolism—NME1—peripheral nervous system neoplasm	6.55e-05	0.00149	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IFNB1—peripheral nervous system neoplasm	6.53e-05	0.00149	CbGpPWpGaD
Lovastatin—HDAC2—Disease—GNS—peripheral nervous system neoplasm	6.52e-05	0.00149	CbGpPWpGaD
Lovastatin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	6.38e-05	0.000354	CcSEcCtD
Lovastatin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.000351	CcSEcCtD
Lovastatin—HMGCR—Metabolism—COX2—peripheral nervous system neoplasm	6.3e-05	0.00144	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	6.29e-05	0.00144	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—PTPN11—peripheral nervous system neoplasm	6.27e-05	0.00143	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	6.22e-05	0.00142	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	6.18e-05	0.00141	CbGpPWpGaD
Lovastatin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.17e-05	0.000342	CcSEcCtD
Lovastatin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	6.15e-05	0.000341	CcSEcCtD
Lovastatin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.00034	CcSEcCtD
Lovastatin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.00034	CcSEcCtD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	6.12e-05	0.0014	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—TP53—peripheral nervous system neoplasm	6.09e-05	0.00139	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—KNG1—peripheral nervous system neoplasm	6.05e-05	0.00138	CbGpPWpGaD
Lovastatin—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.01e-05	0.000333	CcSEcCtD
Lovastatin—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.92e-05	0.000328	CcSEcCtD
Lovastatin—HDAC2—Signaling by NGF—PTPN11—peripheral nervous system neoplasm	5.8e-05	0.00132	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—TP53—peripheral nervous system neoplasm	5.77e-05	0.00132	CbGpPWpGaD
Lovastatin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.73e-05	0.000318	CcSEcCtD
Lovastatin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.71e-05	0.000317	CcSEcCtD
Lovastatin—SLCO1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.7e-05	0.0013	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	5.61e-05	0.00128	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GNS—peripheral nervous system neoplasm	5.57e-05	0.00127	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	5.56e-05	0.00127	CbGpPWpGaD
Lovastatin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	0.000308	CcSEcCtD
Lovastatin—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000307	CcSEcCtD
Lovastatin—ITGAL—Hemostasis—TP53—peripheral nervous system neoplasm	5.5e-05	0.00126	CbGpPWpGaD
Lovastatin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.48e-05	0.000304	CcSEcCtD
Lovastatin—UGT1A3—Metabolism—NME1—peripheral nervous system neoplasm	5.34e-05	0.00122	CbGpPWpGaD
Lovastatin—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.32e-05	0.000295	CcSEcCtD
Lovastatin—UGT1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.32e-05	0.00121	CbGpPWpGaD
Lovastatin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.3e-05	0.000294	CcSEcCtD
Lovastatin—HDAC2—Hemostasis—GNAS—peripheral nervous system neoplasm	5.29e-05	0.00121	CbGpPWpGaD
Lovastatin—Rash—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.000293	CcSEcCtD
Lovastatin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.27e-05	0.000292	CcSEcCtD
Lovastatin—ITGAL—Hemostasis—HRAS—peripheral nervous system neoplasm	5.26e-05	0.0012	CbGpPWpGaD
Lovastatin—Headache—Epirubicin—peripheral nervous system neoplasm	5.24e-05	0.000291	CcSEcCtD
Lovastatin—UGT1A3—Metabolism—COX2—peripheral nervous system neoplasm	5.14e-05	0.00117	CbGpPWpGaD
Lovastatin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000284	CcSEcCtD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	5.12e-05	0.00117	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—HGF—peripheral nervous system neoplasm	5.04e-05	0.00115	CbGpPWpGaD
Lovastatin—Nausea—Epirubicin—peripheral nervous system neoplasm	4.97e-05	0.000276	CcSEcCtD
Lovastatin—ITGAL—Immune System—ERBB2—peripheral nervous system neoplasm	4.96e-05	0.00113	CbGpPWpGaD
Lovastatin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.000273	CcSEcCtD
Lovastatin—Rash—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.000271	CcSEcCtD
Lovastatin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.000271	CcSEcCtD
Lovastatin—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.87e-05	0.00111	CbGpPWpGaD
Lovastatin—Headache—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000269	CcSEcCtD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—peripheral nervous system neoplasm	4.84e-05	0.0011	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.79e-05	0.00109	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.74e-05	0.00108	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GNS—peripheral nervous system neoplasm	4.73e-05	0.00108	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—TP53—peripheral nervous system neoplasm	4.73e-05	0.00108	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.7e-05	0.00107	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—AKT1—peripheral nervous system neoplasm	4.64e-05	0.00106	CbGpPWpGaD
Lovastatin—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.6e-05	0.000255	CcSEcCtD
Lovastatin—HDAC2—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	4.59e-05	0.00105	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NTS—peripheral nervous system neoplasm	4.56e-05	0.00104	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PPP3R1—peripheral nervous system neoplasm	4.56e-05	0.00104	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	4.55e-05	0.00104	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—NME1—peripheral nervous system neoplasm	4.54e-05	0.00104	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.47e-05	0.00102	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	4.46e-05	0.00102	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CD55—peripheral nervous system neoplasm	4.38e-05	0.000998	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—COX2—peripheral nervous system neoplasm	4.37e-05	0.000997	CbGpPWpGaD
Lovastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	4.31e-05	0.000983	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.3e-05	0.00098	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—CASP3—peripheral nervous system neoplasm	4.16e-05	0.00095	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.15e-05	0.000946	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ENO2—peripheral nervous system neoplasm	4.14e-05	0.000944	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	4.12e-05	0.00094	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	4.06e-05	0.000927	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.05e-05	0.000924	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	4.02e-05	0.000916	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	3.95e-05	0.000901	CbGpPWpGaD
Lovastatin—HDAC2—Disease—ENO2—peripheral nervous system neoplasm	3.95e-05	0.000901	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.91e-05	0.000893	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GNS—peripheral nervous system neoplasm	3.85e-05	0.000877	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	3.8e-05	0.000868	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—NRAS—peripheral nervous system neoplasm	3.77e-05	0.00086	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	3.76e-05	0.000859	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	3.72e-05	0.000849	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.7e-05	0.000844	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—NME1—peripheral nervous system neoplasm	3.69e-05	0.000841	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—PTPN11—peripheral nervous system neoplasm	3.68e-05	0.000839	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.67e-05	0.000838	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.61e-05	0.000824	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—COX2—peripheral nervous system neoplasm	3.55e-05	0.00081	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	3.54e-05	0.000807	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	3.52e-05	0.000804	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—BCHE—peripheral nervous system neoplasm	3.49e-05	0.000797	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—NRAS—peripheral nervous system neoplasm	3.49e-05	0.000796	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.48e-05	0.000793	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.46e-05	0.000789	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.46e-05	0.000789	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.4e-05	0.000777	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.39e-05	0.000774	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	3.38e-05	0.000771	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.37e-05	0.00077	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ENO2—peripheral nervous system neoplasm	3.37e-05	0.000769	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.33e-05	0.000761	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—TH—peripheral nervous system neoplasm	3.29e-05	0.00075	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	3.25e-05	0.000742	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	3.23e-05	0.000738	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.23e-05	0.000738	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.19e-05	0.000728	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SLC2A1—peripheral nervous system neoplasm	3.18e-05	0.000726	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.15e-05	0.000718	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	3.1e-05	0.000708	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.09e-05	0.000705	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	2.98e-05	0.000681	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.96e-05	0.000675	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.9e-05	0.000662	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ENO2—peripheral nervous system neoplasm	2.87e-05	0.000654	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—BCHE—peripheral nervous system neoplasm	2.85e-05	0.00065	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.8e-05	0.000639	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—HRAS—peripheral nervous system neoplasm	2.76e-05	0.000629	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.72e-05	0.00062	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GNAS—peripheral nervous system neoplasm	2.68e-05	0.000612	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—TH—peripheral nervous system neoplasm	2.68e-05	0.000611	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ABCB1—peripheral nervous system neoplasm	2.63e-05	0.000601	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—HRAS—peripheral nervous system neoplasm	2.55e-05	0.000582	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.5e-05	0.00057	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.5e-05	0.00057	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.44e-05	0.000557	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—AKT1—peripheral nervous system neoplasm	2.44e-05	0.000556	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—BCHE—peripheral nervous system neoplasm	2.42e-05	0.000553	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.4e-05	0.000547	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.35e-05	0.000537	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	2.34e-05	0.000533	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ENO2—peripheral nervous system neoplasm	2.33e-05	0.000532	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.33e-05	0.000531	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.31e-05	0.000527	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.3e-05	0.000525	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.28e-05	0.00052	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—TH—peripheral nervous system neoplasm	2.28e-05	0.00052	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—AKT1—peripheral nervous system neoplasm	2.25e-05	0.000514	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	2.24e-05	0.000511	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.23e-05	0.000508	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—NRAS—peripheral nervous system neoplasm	2.21e-05	0.000504	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GNAS—peripheral nervous system neoplasm	2.19e-05	0.000499	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	2.16e-05	0.000492	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ABCB1—peripheral nervous system neoplasm	2.15e-05	0.00049	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	2.13e-05	0.000487	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	2.11e-05	0.000481	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.08e-05	0.000474	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.05e-05	0.000468	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.05e-05	0.000467	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	2.02e-05	0.000462	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.01e-05	0.000459	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	1.98e-05	0.000453	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.97e-05	0.000449	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.96e-05	0.000447	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.95e-05	0.000446	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.94e-05	0.000443	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.89e-05	0.000432	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.88e-05	0.000429	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.87e-05	0.000426	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GNAS—peripheral nervous system neoplasm	1.86e-05	0.000424	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.86e-05	0.000424	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—TH—peripheral nervous system neoplasm	1.85e-05	0.000422	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.84e-05	0.00042	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.82e-05	0.000416	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.81e-05	0.000412	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.8e-05	0.000412	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.79e-05	0.000409	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTPN11—peripheral nervous system neoplasm	1.78e-05	0.000406	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.76e-05	0.000403	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.73e-05	0.000395	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.72e-05	0.000393	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	1.7e-05	0.000387	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.69e-05	0.000386	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TP53—peripheral nervous system neoplasm	1.69e-05	0.000386	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.67e-05	0.000381	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.66e-05	0.000379	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.66e-05	0.000378	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.65e-05	0.000376	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.63e-05	0.000371	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.62e-05	0.000369	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—HRAS—peripheral nervous system neoplasm	1.62e-05	0.000369	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.59e-05	0.000364	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.59e-05	0.000363	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.58e-05	0.000361	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.58e-05	0.00036	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	1.56e-05	0.000355	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.53e-05	0.00035	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.52e-05	0.000347	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.51e-05	0.000345	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.5e-05	0.000343	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.48e-05	0.000338	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.48e-05	0.000338	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.45e-05	0.000331	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—AKT1—peripheral nervous system neoplasm	1.43e-05	0.000326	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	1.42e-05	0.000323	CbGpPWpGaD
Lovastatin—HDAC2—Disease—ERBB2—peripheral nervous system neoplasm	1.41e-05	0.000321	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	1.38e-05	0.000316	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.36e-05	0.00031	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	1.27e-05	0.00029	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.25e-05	0.000285	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.25e-05	0.000284	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	1.23e-05	0.00028	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	1.2e-05	0.000273	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.19e-05	0.000272	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.14e-05	0.000261	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	1.13e-05	0.000257	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	1.09e-05	0.00025	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.09e-05	0.000248	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MYC—peripheral nervous system neoplasm	1.07e-05	0.000245	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NRAS—peripheral nervous system neoplasm	1.07e-05	0.000244	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.07e-05	0.000244	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.04e-05	0.000238	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	1.04e-05	0.000237	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.01e-05	0.00023	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.01e-05	0.00023	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1e-05	0.000229	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	9.98e-06	0.000228	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MYC—peripheral nervous system neoplasm	9.97e-06	0.000227	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.89e-06	0.000226	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.85e-06	0.000225	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	9.75e-06	0.000222	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	9.25e-06	0.000211	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	9.19e-06	0.00021	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	9.03e-06	0.000206	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	9.01e-06	0.000206	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.94e-06	0.000204	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.83e-06	0.000201	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	8.7e-06	0.000198	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.61e-06	0.000197	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	8.51e-06	0.000194	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	8.49e-06	0.000194	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	8.44e-06	0.000193	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.12e-06	0.000185	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.05e-06	0.000184	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	8e-06	0.000183	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	7.96e-06	0.000182	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	7.93e-06	0.000181	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HRAS—peripheral nervous system neoplasm	7.83e-06	0.000179	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	7.81e-06	0.000178	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.49e-06	0.000171	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AKT1—peripheral nervous system neoplasm	7.44e-06	0.00017	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AKT1—peripheral nervous system neoplasm	7.24e-06	0.000165	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	7.1e-06	0.000162	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.98e-06	0.000159	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	6.97e-06	0.000159	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	6.93e-06	0.000158	CbGpPWpGaD
Lovastatin—HDAC2—Disease—AKT1—peripheral nervous system neoplasm	6.91e-06	0.000158	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	6.58e-06	0.00015	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	6.53e-06	0.000149	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	6.47e-06	0.000148	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	6.41e-06	0.000146	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	6.35e-06	0.000145	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AKT1—peripheral nervous system neoplasm	5.9e-06	0.000135	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.73e-06	0.000131	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	5.56e-06	0.000127	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.48e-06	0.000125	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.31e-06	0.000121	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	5.23e-06	0.000119	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AKT1—peripheral nervous system neoplasm	5.02e-06	0.000115	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.84e-06	0.00011	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	4.37e-06	9.97e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	4.27e-06	9.74e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	4.19e-06	9.56e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AKT1—peripheral nervous system neoplasm	4.08e-06	9.31e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	3.74e-06	8.53e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	3.43e-06	7.83e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	2.48e-06	5.66e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	2.15e-06	4.9e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.92e-06	4.37e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.87e-06	4.27e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.76e-06	4.02e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.75e-06	3.99e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.15e-06	2.63e-05	CbGpPWpGaD
